tryptophan has been researched along with Airflow Obstruction, Chronic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abel, L; Alfonso, JCL; Arshad, H; Bilitewski, U; Brönstrup, M; Franke, R; Habib, A; Illig, T; Lücke, E; Meyer-Hermann, M; Michaelis, K; Pessler, F; Poliakova, Y; Schreiber, J; Siokis, A; Vila, J | 1 |
Bai, S; Sun, P; Wang, C; Wang, D; Wang, H; Wu, S; Xi, S; Ye, R; Yu, M; Yue, Y; Zhao, L | 1 |
Bernasconi, L; Christ-Crain, M; Henzen, C; Hoess, C; Huber, A; Meier, MA; Mueller, B; Ottiger, M; Schuetz, P; Steuer, C; Thomann, R; Vögeli, A; Zimmerli, W | 1 |
Arru, D; Carru, C; Fois, AG; Mangoni, AA; Pirina, P; Sotgia, S; Sotgiu, E; Zinellu, A; Zinellu, E | 1 |
Barjaktarevic, I; Barr, RG; Bowler, RP; Comellas, AP; Cooper, CB; Curtis, JL; Diao, W; Gu, T; Han, MK; Hansel, NN; He, B; Kanner, RE; Krishnan, JA; Labaki, WW; Martinez, FJ; McDonald, MN; Murray, S; O'Neal, WK; Paine, R; Peters, SP; Standiford, TJ; Stringer, KA; Woodruff, PG; Yeomans, L | 1 |
Broeckling, CD; Griffin, TJ; Gulcev, M; Hodgson, SW; Reilly, C; Sandri, BJ; Wendt, CH; Witthuhn, BA; Woodruff, PG | 1 |
6 other study(ies) available for tryptophan and Airflow Obstruction, Chronic
Article | Year |
---|---|
Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease.
Topics: Asparagine; Biomarkers; Community-Acquired Infections; Convalescence; Humans; Kynurenine; Pneumonia; Pulmonary Disease, Chronic Obstructive; Threonine; Tryptophan | 2022 |
Loss of Pleckstrin homology like domain, family A, member 1 promotes type Ⅱ alveolar epithelial cell apoptosis in chronic obstructive pulmonary disease emphysematous phenotype via interaction with tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activa
Topics: Alveolar Epithelial Cells; Apoptosis; Blood Proteins; Humans; Phenotype; Phosphoproteins; Pulmonary Disease, Chronic Obstructive; Tryptophan; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2022 |
Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Calcitonin; Chromatography, Liquid; Disease Progression; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kaplan-Meier Estimate; Kynurenine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oxygen; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Risk Factors; Serotonin; Switzerland; Tandem Mass Spectrometry; Time Factors; Tryptophan; Tryptophan Hydroxylase | 2017 |
Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients.
Topics: Aged; Biomarkers; Case-Control Studies; Female; Humans; Kynurenine; Logistic Models; Male; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Sensitivity and Specificity; Severity of Illness Index; Tryptophan | 2018 |
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.
Topics: Amino Acids; Female; Humans; Isoleucine; Leucine; Male; Metabolomics; Middle Aged; Patient Outcome Assessment; Proton Magnetic Resonance Spectroscopy; Pulmonary Disease, Chronic Obstructive; Smokers; Tryptophan; Valine | 2019 |
Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Disease Progression; Down-Regulation; Female; Hospitalization; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung; Male; Mass Spectrometry; Metabolomics; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Time Factors; Tryptophan | 2016 |